Aethlon medical announces fiscal year end financial results and provides corporate update

San diego , june 28, 2022 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical technology company focused on developing products to diagnose and treat life and organ threatening infectious diseases, today reported financial results for its fiscal year ended march 31, 2022 and provided an update on recent developments.  company updates aethlon medical is continuing the research and clinical development of the hemopurifier®, a therapeutic blood filtration system that can bind and remove life-threatening viruses and harmful exosomes from blood.
AEMD Ratings Summary
AEMD Quant Ranking